Skip to content

Evaluation of the application of XYZ-110 electronic sphygmomanometer in measuring blood pressure in patients with diabetes mellitu

Evaluation of the application of XYZ-110 electronic sphygmomanometer in measuring blood pressure in patients with diabetes mellitu

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100055006
Enrollment
Unknown
Registered
2021-12-30
Start date
2022-01-01
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

Sponsors

Huaian First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Aged >= 18 years and meet the diagnostic criteria for diabetes: (1) Typical symptoms of diabetes; (2) Add random blood glucose >=11.1 mmol/L or add fasting blood glucose >=7.0 mmol/L or add OGTT 2 h blood glucose >=11.1 mmol/L or add HbA1c >=6.5%.

Exclusion criteria

Exclusion criteria: 1. The patients request to withdraw from the clinical trial; 2. The arm circumference exceeds the allowable range of the sphygmomanometer cuff; 3. Suffering from acute pain or clinical instability; 4. Those with unhealed wounds on the upper arm or those with missing upper arms; 5. Patients with bilateral upper extremity arterial occlusive disease; 6. Patients with mental illness and those who have no insight and cannot express accurately; 7. Disease investigators who believe that it is not appropriate to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
blood pressure;

Countries

China

Contacts

Public ContactWang Bingjian
81370019@QQ.COM+86 13861572900

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026